Advertisement

Regulation of MMP 2 and MMP 9 expressions modulated by AP-1 (c-jun) in wound healing: improving role of Lucilia sericata in diabetic rats

  • Fatma Kübra Tombulturk
  • Tugba Soydas
  • Elif Yaprak Sarac
  • Matem Tuncdemir
  • Ender Coskunpinar
  • Erdal Polat
  • Serhat Sirekbasan
  • Gonul Kanigur-Sultuybek
Original Article
  • 29 Downloads

Abstract

Aims

Lucilia sericata larvae have been successfully used on healing of wounds in the diabetics. However, the involvement of the extraction/secretion (ES) products of larvae in the treatment of diabetic wounds is still unknown. Activator protein-1 (AP-1) transcription, composed of c-jun and c-Fos proteins, has been shown to be the principal regulator of multiple MMP transcriptions under a variety of conditions, also in diabetic wounds. Specifically, MMP-2 and MMP-9’s transcriptions are known to be modulated by AP-1. c-jun has been demonstrated to be a repressor of p53 in immortalized fibroblasts. The aim of the present study is to investigate the effects of L. sericata ES on the expression of AP-1 (c-jun), p53, MMP-2, and MMP-9 in wound biopsies dissected from streptozotocin induced diabetic rats.

Methods

The expression levels of MMP-2, MMP-9, c-jun and p53 in dermal tissues were determined at days 0, 3, 7 and 14 after wounding, using immunohistochemical analysis and quantitative real-time PCR.

Results

The treatment with ES significantly decreased through inflammation-based induction of MMP-2 and MMP-9 expression levels in the wounds of diabetic groups, compared to control groups at the third day of wound healing. At the 14th day, there were dramatic decreases in expression of c-jun, MMP-9, and p53 in ES-treated groups, compared to the diabetic group (P < 0.001, P < 0.05 and P < 0.01, respectively).

Conclusion

ES products of L. sericata may enhance the process of wound healing in phases of inflammation, proliferation, and re-epithelization, essentially via regulating c-jun expression and modulating MMP-2 and MMP-9 expressions.

Keywords

STZ diabetes Maggot debridement therapy Lucilia sericata MMP P53 AP-1 

Notes

Acknowledgements

The concept and design of research belong to FKT and GSK. Animal experiments were carried out by FKT and MT, ES preparation by FKT, EP, and SS, RT-PCR was conducted by FKT and EC. TS and EYS carried out the immunohistochemical analysis. FKT, TS, and EYS performed data analysis, interpretation and writing the article, supervised by GSK. This work was supported by the Scientific Research Project Coordination Unit of Istanbul University (Project number: 35048).

Compliance with ethical standards

Conflict of interest

All authors stated that there is no conflict of interests that could be perceived as prejudicing the impartiality of the research reported.

Ethical standard statement

All procedures performed in studies involving animals were in accordance with the ethical standards of the Animal Ethical Committee of Istanbul University (Approval no. 2013/39).

Informed consent

For this type of study, formal consent is not required.

References

  1. 1.
    Wall SJ, Bevan D, Thomas DW et al (2002) Differential expression of matrix metalloproteinases during impaired wound healing of the diabetes mouse. J Investig Dermatol 119(1):91–98CrossRefGoogle Scholar
  2. 2.
    Martins VL, Caley M, O’Toole EA (2013) Matrix metalloproteinases and epidermal wound repair. Cell Tissue Res 351(2):255–268CrossRefGoogle Scholar
  3. 3.
    Bauvois B (2012) New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta 1825(1):29–36PubMedGoogle Scholar
  4. 4.
    Salo T, Mäkelä M, Kylmäniemi M, Autio-Harmainen H, Larjava H (1994) Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Investig J Tech Methods Pathol 70(2):176–182Google Scholar
  5. 5.
    Bond M, Fabunmi RP, Baker AH, Newby AC (1998) Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-κB. FEBS Lett 435(1):29–34CrossRefGoogle Scholar
  6. 6.
    Qin Z, Balimunkwe RM, Quan T (2017) Age-related reduction of dermal fibroblast size upregulates multiple matrix metalloproteinases as observed in aged human skin in vivo. Br J Dermatol 177(5):1337–1348CrossRefGoogle Scholar
  7. 7.
    Sato H, Seiki M (1993) Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8(2):395–405PubMedGoogle Scholar
  8. 8.
    Benbow U, Brinckerhoff CE (1997) The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 15(8–9):519–526CrossRefGoogle Scholar
  9. 9.
    Fini ME, Bartlett JD, Matsubara M et al (1994) The rabbit gene for 92-kDa matrix metalloproteinase. Role of AP1 and AP2 in cell type-specific transcription. J Biol Chem 269(46):28620–28628PubMedGoogle Scholar
  10. 10.
    Yokoo T, Kitamura M (1996) Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1. Am J Physiol 270(1 Pt 2):F123–F130PubMedGoogle Scholar
  11. 11.
    Shaulian E, Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20(19):2390–2400 (Review) CrossRefGoogle Scholar
  12. 12.
    Knaś M, Niczyporuk M, Zalewska A, Car H (2013) The unwounded skin remodeling in animal models of diabetes types 1 and 2. Physiol Res 62(5):519–526. (Epub 2013 Sep 10) PubMedGoogle Scholar
  13. 13.
    Tombulturk FK, Kasap M, Tuncdemir M et al (2018) Effects of Lucilia sericata on wound healing in streptozotocin-induced diabetic rats and analysis of its secretome at the proteome level. Hum Exp Toxicol 37(5):508–520CrossRefGoogle Scholar
  14. 14.
    Polat E, Aksöz İ, Arkan H, Coşkunpınar E, Akbaş F, Onaran İ (2014) Gene expression profiling of Lucilia sericata larvae extraction/secretion-treated skin wounds. Gene 550(2):223–229CrossRefGoogle Scholar
  15. 15.
    Karipcin FS, Ensari TA, Kayisli UA, Guzel E, Kallen CB, Seli E (2011) The mRNA-binding protein HuR is regulated in the menstrual cycle and repressed in ectopic endometrium. Reprod Sci 18:145–155CrossRefGoogle Scholar
  16. 16.
    Pöppel AK, Kahl M, Baumann A et al (2016) A Jonah-like chymotrypsin from the therapeutic maggot Lucilia sericata plays a role in wound debridement and coagulation. Insect Biochem Mol Biol 70:138–147CrossRefGoogle Scholar
  17. 17.
    Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H (2002) Expression of matrix metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45(7):1011–1016CrossRefGoogle Scholar
  18. 18.
    Fisher GJ, Kang S, Varani J et al (2002) Mechanisms of photoaging and chronological skin aging. Arch Dermatol 138(11):1462–1470CrossRefGoogle Scholar
  19. 19.
    Murakami H, Shimbo K, Inoue Y, Takino Y, Kobayashi H (2012) Importance of amino acid composition to improve skin collagen protein synthesis rates in UV-irradiated mice. Amino Acids 42(6):2481–2489CrossRefGoogle Scholar
  20. 20.
    Fligiel SE, Varani J, Datta SC, Kang S, Fisher GJ, Voorhees JJ (2003) Collagen degradation in aged/photodamaged skin in vivo and after exposure to matrix metalloproteinase-1 in vitro. J Investig Dermatol 120(5):842–848CrossRefGoogle Scholar
  21. 21.
    Quan T, Qin Z, Xia W, Shao Y, Voorhees JJ, Fisher GJ (2009) Matrix-degrading metalloproteinases in photoaging. J Investig Dermatol Symp Proc 14(1):20–24CrossRefGoogle Scholar
  22. 22.
    Bian J, Sun Y (1997) Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol 17:6330–6338CrossRefGoogle Scholar
  23. 23.
    Cohen M, Wuillemin C, Irion O, Bischof P (2008) Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells. Hum Reprod 23(10):2273–2281CrossRefGoogle Scholar
  24. 24.
    Chung SW, Choi BM, Kim JY et al (2017) Altered gene and protein expressions in torn rotator cuff tendon tissues in diabetic patients. Arthroscopy 33(3):518–526CrossRefGoogle Scholar
  25. 25.
    Anderson SS, Wu K, Nagase H, Stettler-Stevenson WG, Kim Y, Tsilibary EC (1996) Effect of matrix glycation on expression of type IV collagen, MMP-2, MMP-9 and TIMP-1 by human mesangial cells. Cell Adhes Commun 4(2):89–101CrossRefGoogle Scholar
  26. 26.
    McLennan SV, Yue DK, Turtle JR (1998) Effect of glucose on matrix metalloproteinase activity in mesangial cells. Nephron 79(3):293–298CrossRefGoogle Scholar
  27. 27.
    Desfaits AC, Serri O, Renier G (1998) Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. Diabetes Care 21(4):487–493CrossRefGoogle Scholar
  28. 28.
    Shiau MY, Tsai ST, Tsai KJ, Haung ML, Hsu YT, Chang YH (2006) Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus. Mt Sinai J Med 73(7):1024–1028PubMedGoogle Scholar
  29. 29.
    Gharagozlian S, Svennevig K, Bangstad H-J, Winberg J-O, Kolset SO (2009) Matrix metalloproteinases in subjects with type 1 diabetes. BMC Clin Pathol 9:7.  https://doi.org/10.1186/1472-6890-9-7 CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Wu SC, Driver VR, Wrobel JS, Armstrong DG (2007) Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag 3:65–76PubMedPubMedCentralGoogle Scholar
  31. 31.
    Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49(11):1603–1616CrossRefGoogle Scholar
  32. 32.
    Kane CD, Greenhalgh DG (2000) Expression and localization of p53 and bcl-2 in healing wounds in diabetic and nondiabetic mice. Wound Repair Regen 8(1):45–45CrossRefGoogle Scholar
  33. 33.
    Davies CE, Wilson MJ, Hill KE et al (2001) Use of molecular techniques to study microbial diversity in the skin: chronic wounds reevaluated. Wound Repair Regen 9(5):332–340 (Review) CrossRefGoogle Scholar
  34. 34.
    López-Boado YS, Wilson CL, Hooper LV, Gordon JI, Hultgren SJ, Parks WC (2000) Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J Cell Biol 148(6):1305–1315CrossRefGoogle Scholar
  35. 35.
    Maeda H, Okamoto T, Akaike T (1998) Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals. Biol Chem 379(2):193–200CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  • Fatma Kübra Tombulturk
    • 1
    • 2
  • Tugba Soydas
    • 1
    • 7
  • Elif Yaprak Sarac
    • 3
  • Matem Tuncdemir
    • 1
  • Ender Coskunpinar
    • 4
  • Erdal Polat
    • 5
  • Serhat Sirekbasan
    • 6
  • Gonul Kanigur-Sultuybek
    • 7
  1. 1.Department of Medical BiologyCerrahpasa Medical Faculty, Istanbul University-CerrahpasaIstanbulTurkey
  2. 2.Medical Laboratory Techniques, Vocational School of Health ServicesIstinye UniversityIstanbulTurkey
  3. 3.Department of Histology and EmbryologyIstanbul Medical Faculty, Istanbul UniversityIstanbulTurkey
  4. 4.Department of Medical Biology, Medical FacultySaglik Bilimleri UniversityIstanbulTurkey
  5. 5.Department of Medical MicrobiologyCerrahpasa Medical Faculty, Istanbul University-CerrahpasaIstanbulTurkey
  6. 6.Department of Biotherapy Research and Development LaboratoryIstanbul UniversityIstanbulTurkey
  7. 7.Department of Medical Biology and GeneticsIstanbul Aydin University, Medical FacultyIstanbulTurkey

Personalised recommendations